MaxCyte, Inc. (LON:MXCT – Get Free Report) passed above its fifty day moving average during trading on Friday . The stock has a fifty day moving average of GBX 0.80 and traded as high as GBX 0.86. MaxCyte shares last traded at GBX 0.85, with a volume of 395,334 shares trading hands.
MaxCyte Trading Up 2.9%
The company has a quick ratio of 14.38, a current ratio of 12.39 and a debt-to-equity ratio of 9.70. The business’s fifty day moving average is GBX 0.80 and its 200 day moving average is GBX 1.18. The stock has a market cap of £926,570.09, a PE ratio of -0.02 and a beta of 1.13.
MaxCyte Company Profile
MaxCyte is a leading cell-engineering company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell-based therapeutics and to support innovative, cell-based research. MaxCyte brings best-in-class technology paired with ongoing support designed to facilitate complex engineering of a wide variety of cells and payloads, with the aim of advancing new treatment options for patients. For over 20 years, MaxCyte has been perfecting the art of cell-engineering, venturing beyond today’s process to innovate tomorrow’s solutions.
See Also
- Five stocks we like better than MaxCyte
- Flutter Sees Post-Earnings Boost as FanDuel Shows Signs of Recovery
- 3 Healthcare Stocks Set to Benefit From the One Big Beautiful Bill
- 3 Under-The-Radar Small Caps Making New All-Time Highs
- 3 Ways to Target the Resources Powering AI and Data Centers
Receive News & Ratings for MaxCyte Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MaxCyte and related companies with MarketBeat.com's FREE daily email newsletter.
